Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

354 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Completed

Beraprost-314d Added-on to Tyvaso® (BEAT)

NCT01908699

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Heart Institute Beverly Hills, California, United States
  • Allianz Research Institute Inc. Fountain Valley, California, United States
  • University of California San Francisco - Fresno Fresno, California, United States
View all 75 locations
View Trial Details
Completed

Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

NCT02279160

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • UCLA Medical Center Torrance, California, United States
View all 35 locations
View Trial Details
Completed

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

NCT00781885

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Harbor-UCLA Medical Center Torrance, California, United States
  • Allegheny General Hospital Pittsburgh, Pennsylvania, United States
  • UTSW Medical Center Dallas, Texas, United States
  • Universite Libre de Bruxelles, Hospital Erasme Brussels, Belgium
View Trial Details
Completed

Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy

NCT01560624

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • Arizona Pulmonary Specialists, Ltd. Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of California, San Francisco-Fresno Fresno, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 155 locations
View Trial Details
Completed

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

NCT00792571

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Harbor-UCLA Medical Center Torrance, California, United States
  • Allegheny General Hospital Pittsburgh, Pennsylvania, United States
  • UTSW Medical Center Dallas Dallas, Texas, United States
  • Universite Libre de Bruxelles Brussels, Belgium
View Trial Details

Related conditions